Cellectar Biosciences Inc

NASDAQ:CLRB   3:18:54 PM EDT
0.38
+0.02 (+5.39%)
Earnings Announcements

Cellectar Reports Financial Results For Year Ended December 2021 And Provides A Corporate Update

Published: 03/21/2022 13:19 GMT
Cellectar Biosciences Inc (CLRB) - Cellectar Reports Financial Results for Year Ended December 2021 and Provides a Corporate Update.
Cellectar Biosciences Inc - Current Balance Sheet Will Fund Our Expected Clinical and Regulatory Milestones Into Second Half of 2023.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.10

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.10

More details on our Analysts Page.